Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing
Back

A New Treatment Option: Adjuvant Nivolumab Following Complete Resection for Stage IIB/C Melanoma

Industry Forum: Bristol Myers Squibb:A New Treatment Option: Adjuvant Nivolumab Following Complete Resection for Stage IIB/C Melanoma

Friday, March 22, 2024
5:15pm – 6:15pm ET
Location: C108
Food and beverage included.